Literature DB >> 4042431

Interaction of mutant lpr gene with background strain influences renal disease.

V E Kelley, J B Roths.   

Abstract

The mutant gene lpr on the MRL/Mp strain of mice is responsible for converting a late onset glomerulonephritis into an early, aggressive, and fatal renal disease. This gene induces the proliferation of a unique subset of lymphocytes, the production of a variety of autoantibodies and shortened survival in MRL/Mp as well as in the genetically distinct strains C3H/HeJ, C57BL/6J, and AKR/J. The present study examined in detail the role of the lpr gene in the formation of lupus nephritis. The results show that C3H-lpr and B6-lpr mice do not develop nephritis while the AKR-lpr strain has a mild form of renal disease. None of these newly constructed congenic mutant strains have the severity of proteinuria or the degree of renal pathology characteristic of MRL-lpr mice. Thus, the lpr gene alone is insufficient in producing severe renal injury. The interaction of the lpr gene with other factors is required for the induction of life-threatening lupus nephritis.

Entities:  

Mesh:

Year:  1985        PMID: 4042431     DOI: 10.1016/0090-1229(85)90153-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  57 in total

1.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

Authors:  Yukihiro Takemura; Noriyuki Ouchi; Rei Shibata; Tamar Aprahamian; Michael T Kirber; Ross S Summer; Shinji Kihara; Kenneth Walsh
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

2.  Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.

Authors:  Y Zhu; Y Yue; S Xiong
Journal:  Clin Exp Immunol       Date:  2018-07-23       Impact factor: 4.330

3.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

4.  A crucial role of the thymus in induction by the lprcg gene of lymphadenopathy with autoimmunity in the mouse.

Authors:  A Matsuzawa; T Moriyama; Y Ogata; T Katagiri; M Kimura
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

5.  Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency.

Authors:  Annemarie Em van Nieuwenhuijze; Bénédicte Cauwe; Denise Klatt; Stéphanie Humblet-Baron; Adrian Liston
Journal:  Immunol Cell Biol       Date:  2015-04-07       Impact factor: 5.126

6.  Partial expression of the lpr locus in the heterozygous state: presence of autoantibodies.

Authors:  B Jachez; E Montecino-Rodriguez; P Fonteneau; F Loor
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

7.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

9.  Nephritogenicity of the lprcg gene on the MRL background.

Authors:  M Kimura; Y Ogata; K Shimada; T Wakabayashi; H Onoda; T Katagiri; A Matsuzawa
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

10.  Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.

Authors:  Caius G Radu; Chengyi J Shu; Evan Nair-Gill; Stephanie M Shelly; Jorge R Barrio; Nagichettiar Satyamurthy; Michael E Phelps; Owen N Witte
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.